Renate Maria Oberhoffer-Fritz

Prof. Dr. Renate Maria Oberhoffer-Fritz

TUM – Technical University of Munich
+1
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Atherosclerosis
Verified
Journal Article
Closed access
RPRobert Dalla Pozza
Robert Dalla Pozza
DEDoris Ehringer-Schetitska
Doris Ehringer-Schetitska
PFPeter Fritsch
Peter Fritsch
EJEero Jokinen
Eero Jokinen
APAndreas Petropoulos
Andreas Petropoulos
APAssociation for European Paediatric Cardiology Working Group Cardiovascular Prevention
Association for European Paediatric Cardiology Working Group Cardiovascular Prevention

30 April 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
BDBirgit Dr.Böhm
Birgit Dr.Böhm
SKSvenja D Karwiese
Svenja D Karwiese
HBHarald Böhm
Harald Böhm
RORenate Maria Oberhoffer-Fritz
Renate Maria Oberhoffer-Fritz
Children and adolescents do not meet the current recommendations on physical activity (PA), and as such, the health-related benefits of regular PA are not achieved. Nowadays, technology-based programs represent an appealing and promising option for children and adolescents to promote PA. The aim of this review was to systematically evaluate the effects of mobile health (mHealth) and wearable activity trackers on PA-related outcomes in this target group. Electronic databases such as the Cochrane Central Register of Controlled Trials, PubMed, Scopus, SPORTDiscus, and Web of Science were searched to retrieve English language articles published in peer-reviewed journals from January 2012 to June 2018. Those included were articles that contained descriptions of interventions designed to increase PA among children (aged 6 to 12 years) only, or adolescents (aged 13 to 18 years) only, or articles that include both populations, and also, articles that measured at least 1 PA-related cognitive, psychosocial, or behavioral outcome. The interventions had to be based on mHealth tools (mobile phones, smartphones, tablets, or mobile apps) or wearable activity trackers. Randomized controlled trials (RCTs) and non-RCTs, cohort studies, before-and-after studies, and cross-sectional studies were considered, but only controlled studies with a PA comparison between groups were assessed for methodological quality. In total, 857 articles were identified. Finally, 7 studies (5 with tools of mHealth and 2 with wearable activity trackers) met the inclusion criteria. All studies with tools of mHealth used an RCT design, and 3 were of high methodological quality. Intervention delivery ranged from 4 weeks to 12 months, whereby mainly smartphone apps were used as a tool. Intervention delivery in studies with wearable activity trackers covered a period from 22 sessions during school recess and 8 weeks. Trackers were used as an intervention and evaluation tool. No evidence was found for the effect of mHealth tools, respectively wearable activity trackers, on PA-related outcomes. Given the small number of studies, poor compliance with accelerometers as a measuring instrument for PA, risk of bias, missing RCTs in relation to wearable activity trackers, and the heterogeneity of intervention programs, caution is warranted regarding the comparability of the studies and their effects. There is a clear need for future studies to develop PA interventions grounded on intervention mapping with a high methodological study design for specific target groups to achieve meaningful evidence.

1 October 2009 in Atherosclerosis
Verified
Journal Article
Closed access
BDBirgit Dr.Böhm
Birgit Dr.Böhm
KHKerstin Hartmann
Kerstin Hartmann
MBMartin Buck
Martin Buck
RORenate Maria Oberhoffer-Fritz
Renate Maria Oberhoffer-Fritz

Verified
Journal Article
Open access
PDF file
Bernhard RauchBernhard Rauch
Bernhard Rauch
ASAnnett Salzwedel
Annett Salzwedel
BBBirna Bjarnason-Wehrens
Birna Bjarnason-Wehrens
CAChristian Albus
Christian Albus
KMKarin Meng
Karin Meng
OGon behalf of the Cardiac Rehabilitation Guideline Group
on behalf of the Cardiac Rehabilitation Guideline Group
Background: Although cardiovascular rehabilitation (CR) is well accepted in general, CR-attendance and delivery still considerably vary between the European countries. Moreover, clinical and prognostic effects of CR are not well established for a variety of cardiovascular diseases. Methods: The guidelines address all aspects of CR including indications, contents and delivery. By processing the guidelines, every step was externally supervised and moderated by independent members of the “Association of the Scientific Medical Societies in Germany” (AWMF). Four meta-analyses were performed to evaluate the prognostic effect of CR after acute coronary syndrome (ACS), after coronary bypass grafting (CABG), in patients with severe chronic systolic heart failure (HFrEF), and to define the effect of psychological interventions during CR. All other indications for CR-delivery were based on a predefined semi-structured literature search and recommendations were established by a formal consenting process including all medical societies involved in guideline generation. Results: Multidisciplinary CR is associated with a significant reduction in all-cause mortality in patients after ACS and after CABG, whereas HFrEF-patients (left ventricular ejection fraction <40%) especially benefit in terms of exercise capacity and health-related quality of life. Patients with other cardiovascular diseases also benefit from CR-participation, but the scientific evidence is less clear. There is increasing evidence that the beneficial effect of CR strongly depends on “treatment intensity” including medical supervision, treatment of cardiovascular risk factors, information and education, and a minimum of individually adapted exercise volume. Additional psychologic interventions should be performed on the basis of individual needs. Conclusions: These guidelines reinforce the substantial benefit of CR in specific clinical indications, but also describe remaining deficits in CR-delivery in clinical practice as well as in CR-science with respect to methodology and presentation.

LWLaura Willinger
Laura Willinger
LBLeon Brudy
Leon Brudy
MMMichael Meyer
Michael Meyer
RORenate Maria Oberhoffer-Fritz
Renate Maria Oberhoffer-Fritz
PEPeter Ewert
Peter Ewert
JMJan Müller
Jan Müller
Background: Overweight and obesity have become a major public health concern in recent decades, particularly in patients with chronic health conditions like congenital heart disease (CHD). This systematic review elaborates on the prevalence and the longitudinal development of overweight and obesity in children and adults with CHD. Methods: A systematic literature search was conducted in PubMed, Cochrane, and Scopus from January 2010 to December 2020 on overweight and obesity prevalence in children and adults with CHD. Results: Of 30 included studies, 15 studies evaluated 5680 pediatric patients with CHD, 9 studies evaluated 6657 adults with CHD (ACHD) and 6 studies examined 9273 both pediatric patients and ACHD. Fifteen studies received the quality rating “good”, nine studies “fair”, and six studies “poor”. In children with CHD, overweight prevalence was between 9.5–31.5%, and obesity prevalence was between 9.5–26%; in ACHD, overweight prevalence was between 22–53%, and obesity was between 7–26%. The prevalence of overweight and obesity was thereby similar to the general population. Overweight and obesity have been shown to increase with age. Conclusion: The prevalence of overweight and obesity in children and adults with CHD is similar to the general population, demonstrating that the growing obesity pandemic is also affecting the CHD population.

22 January 2013 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
JMJan Müller
Jan Müller
BDBirgit Dr.Böhm
Birgit Dr.Böhm
SSSebastian Semsch
Sebastian Semsch
RORenate Maria Oberhoffer-Fritz
Renate Maria Oberhoffer-Fritz
JHJohn Hess
John Hess
AHAlfred Hager
Alfred Hager
In several former studies, adolescents and adults with congenital heart disease (CHD) had a reduced exercise capacity even with defects considered to be simple. Currently, children might get better medical management and less restrictions concerning an active lifestyle or sports activities. The exercise performance of this new generation of children with CHD has to be evaluated. In the year 2010, 88 children (12.7 years, 52 males), 11–14 years old, with various CHD performed a cardiopulmonary exercise test in our institution. These children were matched for age and gender with healthy subjects who underwent the same procedure at a school survey. In comparison with healthy controls, children with CHD had a diminished peak oxygen uptake (CHD: 35.5 ml/min/kg vs controls: 42.4 ml/min/kg; P < 0.001) corresponding to 87.1% (CHD) and 99.5% (Controls) of the reference value, respectively. Peak oxygen uptake decreased with the severity of the heart defect (r = −0.410; P < 0.001). However, there was no difference in oxygen uptake at the ventilatory threshold (CHD: 20.6 ml/min/kg vs controls: 21.5 ml/min/kg; P = 0.68). Currently, children with CHD are not limited in their submaximal exercise performance. However, there is still a reduction in peak oxygen uptake.